Phase I/II clinical trial - Gynécologie - Ovaires
PiSARRO
Gynécologie - Ovaires
Essai clinique fermé
Public cible
Adulte
p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin/Pegylated Liposomal Doxorubicin Combination Chemotherapy With or Without APR-246.
Description de l'essai
Ovarian cancer.
Liens utiles
PAUL-HENRI COTTU
Investigateur principal